Summary.-A 51Cr-release test was developed for the detection of cell-mediated cytotoxicity against transplanted solid chemically induced rat tumours, and the findings were compared with those obtained in parallel tests using a microcytotoxicity assay. It was necessary to incorporate several modifications of the original Brunner assay (Brunner et al., 1968) in order to increase the sensitivity of the test as applied to long-term tumour lines maintained as glass-adherent cultures. These included: 1.
Summary.-A 51Cr-release test was developed for the detection of cell-mediated cytotoxicity against transplanted solid chemically induced rat tumours, and the findings were compared with those obtained in parallel tests using a microcytotoxicity assay. It was necessary to incorporate several modifications of the original Brunner assay (Brunner et al., 1968) in order to increase the sensitivity of the test as applied to long-term tumour lines maintained as glass-adherent cultures. These included: 1. preincubation of labelled tumour cells at 37°C for 3-4 h before addition of effector cells; 2. preincubation of effector cells at 37°C for 12 h before addition to target cells; 3. upon admixture of target and effector cells, intimate cell contact was established by gentle centrifugation; 4. after incubation of target and effector cells at 37°C, a further incubation for 1 h at 45°C was included to complete the release of 51Cr from non-viable cells. Maximal cytotoxicity of tumour-bearer effector cells was detected after 12 h incubation of lymphoid and target cells at a ratio of 200:1.
Spleen cells from tumour-bearing rats during the first 2 weeks of tumour growth exhibited the same pattern of reactivity in the 5'Cr-release test and the microcytotoxicity assay, although significant reduction in target-cell numbers was more frequently recorded using the microcytotoxicity assay. Tumour-bearer spleen cells showed reactivity against the homologous tumour as well as against unrelated tumours. Using either assay, pre-exposure of effector cells to 3M KCI extracts of tumour was found to inhibit their effect on tumour cells most frequently in tests in which the effector -cell donor, soluble extract and target cell were of the same tumour line.
THE 51Cr-release test and the microcytotoxicity assay represent 2 important test systems in common use for the demonstration of lymphoid cell-mediated cytotoxic reactions against tumour cells. A major use of the 51Cr-release test in the study of tumour immunity has been with suspension cultures of tumour cells of lymphoid origin. The test is considered to generate data which reflect direct cell lvsis (Cerottini and Brunner, 1974) . Conversely, with the microcytotoxicity assay (Takasugi and Klein, 1970; Hellstrom et al., 1971 ) cell lysis and cytostasis, as well as impairment of cell functions leading to detachment from plastic surfaces, may be measured by visual counting of remaining adherent tumour cells. Disparities between the assays may be the product of the particular assay employed (e.g. Plata et al., 1974) or may be due to the different nature of effector cells and cytotoxic pathways operating in these tests. Evidence has been obtained that in the shortterm 51Cr-release test, cytolysis is mediated by T cells (Leclerc et al., 1973; Cerottini and Brunner, 1974) . The situation with the microcytotoxicity assay is less well defined and both T (Fossati, Holden and Herberman, 1975) and non-T (Plata et Herberman (1972) suggest that the cytotoxicity of lymphoid cells may involve in vitro activation of cellular immune response during incubation. Possibly, depending on the test conditions, both assays may detect T, B and nonlymphoid cell killing, which could explain that no consistent differences were detected between the 2 assays when cytotoxic responses of T-or B-enriched subfractions were tested in both assays (e.g. Hersey et al., 1975) . A further possibility is that during the 48-h incubation of target and effector cells in the microcytotoxicity assay, 2 T-cell populations may be active: cytotoxic T cells as well as initially nonlytic secondary T cells which acquire cytotoxic reactivity during the first 24 h of the test period (Trostmann et al., 1976) .
The present study describes an attempt to modify the Brunner 5'Cr-release test (Brunner et al., 1968) in order to allow evaluation of tumour-bearer lymphoidcell-mediated cytotoxicity to cells from transplanted solid chemically induced rat tumours, cultured as long-term, glassadherent cell lines. For comparative purposes, parallel tests were performed using the microcytotoxicity assay. The sensitivities of the 2 test systems were also compared in their ability to detect inhibition of cytotoxicity after brief exposure of effector cell preparations to extracts containing soluble tumour antigen.
MATERIAL AND METHODS
Target tumour cells and lymphoid cells.-Cell cultures from the transplanted rat hepatomas D191 and D192 and sarcomas Mc7 and Mc57 were used. Details of the establishment and maintenance of these cell lines have been previously described, and the preparation of tumour-bearer lymph-node cells (LNC) and spleen cells, as well as lymphoid cells from normal donors, was also carried out according to Zoller, Price and Baldwin (1975) . Lymphoid cells used in the 51Cr-release test were separated by gradient centrifugation on Ficoll-Triosil (Boyum, 1968) Table I .
Tests with tumour-bearer lymphoid cells which gave a % 51Cr release greater than the mean % 51Cr release plus two standard deviations for cells from that tumour line in the presence of normal lymphoid cells, were taken to represent a significant cytotoxic reaction (Table I) . 0-5±2-1 0 * 7±2 * 9 1 *0±2-0 0-5±2 *4 4-7 6 -5 5 0 5-3 * These values are the lower limit for significant release of 5'Cr with tumour-bearer lymphoid cells.
Microcytotoxicity assay.-The microcytotoxicity assay was performed using an effector cell to target cell ratio of 1000 : 1 as previously described (Zoller et al., 1975 In order to reveal cell-mediated reactivity, it was necessary to incubate lymphoid cells for 12 h at 3700 before addition to tumour target cells. The optimal ratios of effector: target cell were determined to be 200 : 1 and 100: 1, since with lower numbers of lymphoid cells no cytotoxicity was detected in tumourbearer effector-cell preparations, whereas when higher numbers of lymphoid cells were tested (at effector : target cell ratios of 500 : 1, 1000 : 1 and 2000: 1) the release of radiolabel declined: i.e. the percentage release of 51Cr from target cells in the presence of normal and tumourbearer lymphoid cells was reduced. In such a situation it was not possible to determine meaningful values for tumourbearer effector-cell cytotoxicity by comparison with medium control samples. As shown in Table I , at the ratios of 200: 1 and 100: 1, the mean 5TCr release in samples with normal lymphoid cells did not differ from medium control samples by more than approximately 1%. Fig. 1 illustrates the results of a representative time-course study using hepatoma D192-bearer lymph-node and spleen cells. In this experiment, as well as in comparable time-course studies with other target-cell lines, there was little indication of significant cytotoxic reaction before at least 8 h and the effect was most pronounced after incubation for 12 h. After incubation for 18 h or longer, a high release of 51Cr was obtained in samples exposed to either tumour-bearer or normal lymphoid cells, making a calculation of cytotoxicity by comparison with the medium control samples unacceptable.
When calculating the specific 5'Cr release (Fig. 1) by comparison to samples with normal lymphoid cells, the loss in sensitivity was shown by a reduction of the specific 5'Cr release.
No difference in the cytotoxic activities of tumour-bearer lymph-node, spleen and peritoneal cells were detected. Furthermore, the depletion of macrophages by carbonyl iron treatment did not alter the cytotoxicity significantly. This is demonstrated for D191 target and effector cells in Table II .
In all subsequent tests described, an incubation period of 12 h was employed, and spleen cells were used exclusively as effector cells at a ratio of 200 1 to the target tumour cells.
Characterization of tumour-bearer effectorcell cytotoxicity
Using the criterion of significance defined in Material and Methods, the showed broadly similar susceptibility as release of 51Cr in the presence of tumourbearer spleen cells in either specific or cross test combinations. The highest incidence of cytotoxicity was observed using effector cells from rats bearing their tumour for 5-7 days. This is shown in specific and cross test combinations for spleen cells from D191-tumour-bearing rats (Table IV) . After more than 2 weeks of tumour growth, tumour-bearer lymphoid-cell reactivity was diminished. The (Table V) .
Comparison between the 51Cr-release test and the microcytotoxicity assay 
DISCUSSION
The aim of the present study was to develop a 51Cr-release test for the detection of cell-mediated immune reactions and to evaluate it for the assay of tumourbearer spleen-cell cytotoxicity using solid chemically induced rat hepatomas and sarcomas. In preliminary tests, it was determined that the optimal incubation period for the detection of cytotoxic reactions was 12 h. With periods up to 8 h incubation, the release of 51Cr from cells exposed to tumour-bearer and to normal lymphoid cells was essentially the same. By employing incubation periods much greater than 12 h, a rapid increase of non-specifically released 51Cr from labelled tumour cells in the presence of normal and tumour-bearer effector cells prevented the detection of 51Cr release by cell-mediated cytolysis. We assume that the high unspecific release after more than 12 h incubation is probably due to nutrient deprivation, especially because in samples in which target cells were incubated with medium alone, only a slight increase in the 5'Cr release was observed.
The modifications of the assay of Brunner et al. (1968) adopted to maximize the sensitivity of the test, are summarized in Table VI . The preincubation of labelled target cells for 3-4 h at 37°C allowed the release of cell-surface-bound label. This was necessary in order to reduce the spontaneous release over the long incubation period of 12 h. Effector cells were preincubated for 12 h at 37°C and then washed x 5, such procedure being designed to reveal cytotoxicity in previously non-cytotoxic cell preparations, and to remove bound serum inhibitory factors (Laux and Lausch, 1974; Currie and Basham, 1972; Currie, 1973) . Only small improvements were noted by this procedure, taking effector cells from tumour-bearing rats. But (Zoller, unpub.) .
Further small improvements were achieved by intimate cell-to-cell contact (gentle centrifugation of the target-effector cell mixture, Thorn, Palmer and Manson, 1974) and by a final incubation at 45°C for 1 h, which was adopted to enhance the (Dunkley, Miller and Shortman, 1974 al., 1975, 1976) .
The same features of reactivity as detected with the microcytotoxicity assay are now described for the 51Cr-release test. Again, a cytotoxic response was observed soon after tumour implantation. The highest incidence of cytotoxic reactions was found on Days 5 to 7 (Table III) and cytotoxicity was abolished after 14 to 18 days, depending on the tumour burden. This phenomenon has been described by other authors (Barski and Youn, 1969; LeFrancois et al., 1971) The present work demonstrates that it is possible to measure cytotoxic reactions against long-term glass-adherent tumour target cells from solid chemically induced tumours with the 51Cr-release test. However, it should be noted that significant cytotoxic reactions, as well as significant inhibition of cytotoxic responses, were more frequently detected by the microcytotoxicity assay. From this we concluded that the microcytotoxicity assay is the more sensitive assay for detecting tumour-bearer effector-cell cytotoxicity against target cells from solid chemically induced tumours. But the 5'Cr-release test will prove very useful where a distinction between, for example, cytolytic effects and adherence inhibition is attempted.
It is widely held that T-cell-mediated cytotoxicity accounts (at least in part) for the effects observed with both the microcytotoxicity assay and the 5'Cr-release test. In the short-term 51Cr-release test, non-T-cell effects can be predominantly excluded. With respect to the microcytotoxicity assay, various effector-cell types and mechanisms are discussed. In our system of chemically induced rat hepatomas and sarcomas it is not known whether T or non-T cells are responsible for the cytotoxic reactions of tumour--84 1 bearer effector cells. Preliminary data showed that 51Cr release is not induced by macrophages, since carbonyl-iron treatment of tumour-bearer effector cells did not depress 51Cr release (Table II) . We cannot make any further apportionment to T or non-T cell killing in our system. With respect to the cytotoxic cell population, the results of Trostmann et al. (1976) , who has investigated, with both the microcytotoxicity assay and the 51Cr-release test, the cytotoxic effector cell in an allogeneic model, should be mentioned, because the test conditions were very similar to ours. Trostmann and his colleagues found that in their system, only T-cell killing was measured in both the microcytotoxicity assay and in the 51Cr release test, but that two T-cell populations were responsible for the target-cell killing, one of which first had to be activated. This primarily non-lytic T-cell population was activated during the 48-h incubation of the microcytotoxicity assay, but was inactive in the short-term 51Cr-release test, unless incubated with medium (partial activation) or with the appropriate target cell (full activation) before admixture of target and effector cells in the 51Cr-release test. Those findings could well explain our results, but further studies are needed to clarify the question of T or non-T cell killing in tumour-bearer effector-cell cytotoxicity against target cells from solid chemically induced tumours.
